Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-08-12 VATERS ROBERT S President & CFO Purchase +12,385 $1.35 $17K 228,750
2015-08-11 VATERS ROBERT S President & CFO Purchase +81,000 $1.24 $100K 216,365
2015-06-02 VATERS ROBERT S President & CFO Grant or award +60,000 135,365
2015-01-16 VATERS ROBERT S President & CFO Grant or award +137,028 137,028
2015-01-16 VATERS ROBERT S President & CFO Shares withheld for taxes −61,663 $3.48 $215K 75,365
2015-01-16 VATERS ROBERT S President & CFO Returned to the company · Stock Option (right to purchase) −80,000 400,000
2015-01-16 VATERS ROBERT S President & CFO Returned to the company · Stock Option (right to purchase) −120,000 0
2015-01-05 VATERS ROBERT S President & CFO Grant or award · Stock Option (right to purchase) +480,000 480,000
2015-01-05 VATERS ROBERT S President & CFO Grant or award · Stock Option (right to purchase) +120,000 120,000

Page 1 of 1 · 9 trades